BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22525428)

  • 1. Loss of microRNA-205 expression is associated with melanoma progression.
    Liu S; Tetzlaff MT; Liu A; Liegl-Atzwanger B; Guo J; Xu X
    Lab Invest; 2012 Jul; 92(7):1084-96. PubMed ID: 22525428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma.
    Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X
    J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.
    Liu S; Tetzlaff MT; Cui R; Xu X
    Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
    Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
    Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.
    Matsushima K; Isomoto H; Yamaguchi N; Inoue N; Machida H; Nakayama T; Hayashi T; Kunizaki M; Hidaka S; Nagayasu T; Nakashima M; Ujifuku K; Mitsutake N; Ohtsuru A; Yamashita S; Korpal M; Kang Y; Gregory PA; Goodall GJ; Kohno S; Nakao K
    J Transl Med; 2011 Mar; 9():30. PubMed ID: 21426561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
    Lu YM; Shang C; Ou YL; Yin D; Li YN; Li X; Wang N; Zhang SL
    Med Oncol; 2014 Aug; 31(8):134. PubMed ID: 25052237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
    Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
    J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
    Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
    J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM; Gaur AB; Lengyel E; Peter ME
    Genes Dev; 2008 Apr; 22(7):894-907. PubMed ID: 18381893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
    Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
    Mod Pathol; 2008 Mar; 21(3):326-33. PubMed ID: 18204435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-200b regulates cell migration via Zeb family during mouse palate development.
    Shin JO; Nakagawa E; Kim EJ; Cho KW; Lee JM; Cho SW; Jung HS
    Histochem Cell Biol; 2012 Apr; 137(4):459-70. PubMed ID: 22261924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M; Lee ES; Hu G; Kang Y
    J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.
    Zhang P; Huang C; Fu C; Tian Y; Hu Y; Wang B; Strasner A; Song Y; Song E
    Oncotarget; 2015; 6(12):9834-53. PubMed ID: 25868853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
    Guo F; Cogdell D; Hu L; Yang D; Sood AK; Xue F; Zhang W
    Oncol Rep; 2014 May; 31(5):2021-8. PubMed ID: 24677166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.
    Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J
    Int J Oncol; 2016 Feb; 48(2):541-50. PubMed ID: 26648487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.